Publication | Closed Access
The ErbB2 inhibitor Herceptin (Trastuzumab) promotes axonal outgrowth four weeks after acute nerve transection and repair
17
Citations
29
References
2014
Year
Erbb2 Inhibitor HerceptinNeuroregenerationPeripheral Nerve InjuryWound HealingNeurologyNeural Tissue EngineeringAcute Nerve TransectionPeripheral NervesMedicineCell BiologyPeripheral NerveMicrosurgical Nerve Repair
| Year | Citations | |
|---|---|---|
Page 1
Page 1